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Objectives: Autonomic modulation is adversely impacted in patients with chronic obstructive
pulmonary disease (COPD). The purpose of the present investigation is to assess the effects of
a 6-week aerobic exercise training program on autonomic modulation of heart rate in patients
with COPD.
Methods: Forty patients of both sexes with moderate-to-severe COPD were randomly allocated
to aerobic exercise training (PT, nZ 20) or to usual care (Control, nZ 20). The training
program consisted of lower and upper limb stretching and 30 min of treadmill exercise, 3 times
per week for a 6-week period. Physiological data during symptom-limited exercise testing and
the six-minute walk test (6MWT) were assessed. In addition, ReR intervals were obtained at
rest and during the 6MWT. Heart rate variability was analyzed by time (rMSSD and SDNN index)
and frequency domains (high frequency e HF, low frequency e LF and HF/LF ratio).
Results: Peak oxygen consumption significantly improved in the training group only (p< 0.05).
Moreover, the training group demonstrated significant improvements (p < 0.05) in blood
lactate, minute ventilation, dyspnea at peak exercise, sympathetic activity, and parasympa-
thetic activity at rest and during submaximal exercise. Lastly, a positive and significant corre-
lation was found between change in 6MWT distance and rMSSD index (rZ 0.65 and pZ 0.001).3351 8952; fax: þ55 16 3361 2081.
(A. Borghi-Silva).
hed by Elsevier Ltd.
1504 A. Borghi-Silva et al.Conclusions: Neural control of heart rate, in addition to other clinically valuable measures, is
positively altered in moderateesevere COPD patients following 6 weeks of aerobic exercise
training. The improvement in submaximal performance after exercise training was associated
with parasympathetic activity.
Published by Elsevier Ltd.Introduction
Cardiovascular autonomic neuropathy is a common conse-
quence of chronic obstructive pulmonary disease (COPD).1,2
Previous studies have demonstrated that this patient pop-
ulation has depressed heart rate variability (HRV), indi-
cating increased sympathetic activity, at rest1,2 as well as
during sleep3 and physical exercise.4 As a result, arrhyth-
mias are common in patients with COPD, contributing to
the documented increase risk of sudden cardiac death in
this chronic disease population.5e7
The main cause of reduced HRV in patients with COPD is
unclear. Plausible pathophysiologic mechanisms leading to
reduced HRV in COPD include broncoconstriction,2 hypoxia,8
hypercapnia,3 medications,5e7 weight loss9 and systemic
inflammation.9,10 Recently, it has been suggested that
cardiac autonomic function in patients with COPD is related
to level of physical activity and muscle strength,11 similar to
findings reported in patients with chronic heart failure.12
Increasing COPD disease severity promotes a negative
impact on exercise tolerance and magnifies the level of
disability. Physical activity programs appear to safely
ameliorate these COPD consequences, conferring beneficial
effects on dyspnea and health-related quality of life.13,14
The positive effects of exercise training on autonomic
modulation have been reported in patients with cardiac
disease and may help to explain the well-documented
prognostic improvement in this population.15e17 However,
the effect of an aerobic exercise training program on
autonomic modulation in patients with COPD has yet to be
investigated. To address this gap in the literature, the aim
of this study was to evaluate the impact of an aerobic
exercise program on autonomic modulation in patients with
moderate-to-severe COPD. We hypothesized that a six-
week aerobic exercise program will improve both exercise
performance and autonomic modulation in patients diag-
nosed with this chronic disease.Methods
Design and study population
This is a prospective randomized controlled trial. A total of
125 patients were screened, from which forty patients of
both sexes were included in the study (Fig. 1). Exclusion
criteria consisted of: 1)the presence of orthopedic or
neurological conditions that would preclude participation
in an exercise program, 2) a history of cardiac arrhythmias
or potential ECG alterations, 3) a past history consistent
with heart disease, diabetes mellitus, uncontrolled hyper-
tension, or other concomitant respiratory diseases, and 4)
failure to comply with the research protocol. In thiscontext, 85 patients were not included in the study due
to concomitant ischemic cardiac disease (nZ 10), diabetic
neuropathy (nZ 2), chronic peripheral arterial disease
(nZ 3), aortic aneurysm (nZ 1); hypertension (nZ 10),
respiratory disease (associated with sequelae of tubercu-
losis nZ 4, with bronchiectasis nZ 2 and with cancer
nZ 2), ECG alterations (chronic atrial fibrillation (nZ 4);
heart block (nZ 3), frequent ventricular premature beats
(nZ 5); musculoskeletal diseases (nZ 6 with severe
arthrosis of knee and hip; 1 with hip prosthesis; 5 with
sequelae of stroke, 1 with Parkinson and 1 with alcoholic
myopathy). In addition, 9 patients declined participation
without citing a reason while the final 16 patients cited
transportation issues as a primary reason for declining study
participation. Patients that were included presented: 1)
a diagnosis of COPD according to criteria set forth by the
Global Initiative for Chronic Obstructive Lung Disease
(GOLD),18 2) compliance with medical management, 3) no
change in medical management and no decompensation
episodes for at least one month prior to study initiation,
and 4) no participation in a regular physical exercise
program for at least six months prior to study initiation.
Patients were randomly assigned to a supervised aerobic
training program (TG) or to a control group (CG), without
aerobic training.
All patients received regular treatment consisting of
inhaled bronchodilators and steroids. None of the patients
were prescribed oral steroids, antibiotics, antihyperten-
sives or beta-blockers. The study protocol was approved by
the Institutional Ethics Committee and all patients signed
a written consent form prior to study initiation.
Measurements
All subjects were evaluated during the same time of the
day (in order to avoid differences in response due to
circadian rhythm) at an experimental room temperature of
22 C with relative air humidity between 50% and 60%.
Subjects were instructed to abstain from caffeinated and
alcoholic beverages and not to perform exercise on the
day before data collection.
Lung function: Spirometric tests were performed using
a portable spirometer (Hand Held 2120, Vitalograph, Ennis,
Ireland) with a calibrated pneumotachograph. Maximal
inspiratory/expiratory maneuvers were performed and
FEV1, VC, FVC, FEF25-75% and maximum voluntary venti-
lation were determined from the best out of three trials.19
Maximal inspiratory (PImax) and expiratory pressure
(PEmax) were measured using an analogic manovacumeter
with a cmH2O scale (Ger-ar; Sa˜o Paulo, SP, Brazil) according
to the method previously described.20
Cardiopulmonaryexercise testing: Incremental symptom-
limited exercise test was performed in accordance with the
Figure 1 Flowchart showing patient participation in the study.
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ergometric tests were performed using a computer-based
ventilatory expired gas analysis system (VO2000, Med-
graphics Corp., St. Paul, MN). The VO2000 uses a galvanic
fuel cell for the oxygen analyzer (range 0e96%) and
a non-dispersive infrared carbon dioxide analyzer (range
0e10%), both of which were calibrated prior to each exer-
cise test as per manufacture instructions. A Pitot tube
(prevent Pneumotach, MGC) of low flow pneumotach
(range 2e30 L min1) was also calibrated with a 3-L volume
syringe. The flow device was connected to a buccal and the
nostrils were occluded by a nose clip. Acceptable inter-day
reliability for _VE (CV 7.3e8.8%) and for _VO2, and _VCO2
(CV 5.3e6.0%) has been evaluated in a previous study.22
The following 15-s averaged ventilatory gas data were
recorded: oxygen consumption ( _VO2, in mLmin
1 and
mL kg1 min1), carbon dioxide production ð _VCO2Þ, minute
ventilation ( _VE, L min1), respiratory rate (rpm), and tidal
volume (VT, L). Oxyhemoglobin saturation (SpO2, %) was
determined by pulse oximetry (Nonim 8500A Plymouth,
Minnesota, USA). Subjects were also asked to rate their
‘‘shortness of breath’’ at exercise cessation using the 0e10
Borg’s category-ratio scale23: symptom scores were
expressed in absolute values and corrected for exercise
duration.
Capillary samples were collected from the ear lobe for
blood lactate measurements (mEq L1) at exercise peak21(Yellow Springs 1500 Sport, Yellow Springs Instruments, OH,
USA).
Six-minute walk test (6MWT): The 6MWT was performed
in a 30-m corridor as described by ATS Guidelines.24 Dysp-
nea, as measured with Borg’s CR10 scale22; SpO2 and pulse
rate by pulse oximetry at the start and end of the 6MWT.
Two tests were performed on alternate days before treat-
ment and the results of the second test were used given the
first test tends to underestimate exercise capacity due to
subject’s lack of familiarity with the procedure.24 Each
patient was instructed to walk from one end of the corridor
to the other, covering as much ground as possible during the
allotted time and received standardized encouragement
throughout the test.
Acquisition of ReR interval(ReRi): ReRi was registered
using the Polar system at rest in both the supine (10 min)
and seated position (10 min) and during the 6MWT. An
elastic belt (Polar T31 transmitter, Polar Electro, Kempele,
Finland) was attached to the chest of the volunteer at the
level of the lower third of the sternum. The belt contains
a stable case with heart rate electrodes, an electronic
processing unit, and an electromagnetic field transmitter.
The heart rate signals are continuously transmitted to the
Polar Advantage receiver unit via an electromagnetic field.
The digitally coded ReRi length is continuously transferred
to the Polar Precision Performance software that in turn
displays a heart rate tachogram on the monitor.25
Table 1 Age, anthropometric characteristics and lung
function on baseline in COPD groups and control group.
TG CG p level
(nZ 20) (nZ 14)
Demographic/anthropometric
Age (years) 67 10 67 10 0.82
Gender (M/F) 13/7 12/8 0.33
Height (cm) 161 11 160 10 0.66
Weight (kg) 63 13 65 16 0.64
BMI (kg m2) 25 4 24 5 0.88
Pulmonary function
SpO2 (%) 91 2 91 3 0.64
FVC (L) 1.9 0.6 1.8 0.7 0.33
FVC (% pred) 64 16 64 18 0.93
FEV1 (L) 0.80 0.3 0.76 0.3 0.67
FEV1 (% pred) 33 9 35 11 0.60
FEV1/FVC 42 10 46 12 0.35
MIP (cmH2O) 44 25 38 15 0.43
MEP (cmH2O) 66 24 70 23 0.68
Values expressed in mean and standard deviation. TG: training
group; CG: control group; M: males; F: females; BMI: body mass
index; SpO2: peripheral oxygen saturation measured by pulse
oximetry; FVC: forced vital capacity; FEV1: forced expiratory
volume in 1.0 s; MIP and MEP: maximal inspiratory and expira-
tory pressures;
No significant differences between TG vs. CG (p> 0.05).
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ReR intervals were collected during 10 min of rest and
throughout the 6MWT. The sections selected for HRV anal-
ysis were deemed the most stable sections, containing 256
ReR intervals or more points in both situations. During the
6MWT, we discarded the initial 60 s of data and selected the
most stable signal, corresponding to the latter portion of
the test. HRV was analyzed by time (rest and exercise) and
frequency domain methods (only during rest) by a specific
routine developed in Matlab V. 6.1 software. In the time
domain analysis, the standard deviation of the normal ReR
intervals (SDNN), that is the square root of variance, and
the square root of the mean sum of the squares of the
difference between adjacent normal ReR intervals within
a given time minus one (rMSSD) were analyzed.26
In the frequency domain analysis, the power spectral
components were reported at low (0.04e0.15 Hz) and high
(0.15e0.4 Hz) frequencies using the Fast Fourier Trans-
formation. The data, calculated by the total power less the
power of the component with a frequency range between
0 and 0.03 Hz (i.e. at very low frequency), were expressed
in absolute and normalized units and as a low/high
frequency ratio.26
Exercise training program
The 6-week physical exercise program was conducted on an
outpatient basis. Aerobic exercise training consisted of
stretching of lower and upper limbs and treadmill ambu-
lation for 30 min. The training intensity on treadmill was set
at 70% of the maximal speed achieved during the symptom-
limited exercise test. Stretching exercises for the
hamstrings, quadriceps, calves, shoulders, neck and lower
back were performed before and after each session over
a 10-min period. During the stretching exercises, the
physiotherapist emphasized diaphragmatic breathing and
awareness of proper posture in front of a mirror in the
position standing and sitting. During the training sessions,
the patient’s HR and SpO2 were continuously monitored.
The sessions were supervised by a physical therapist, 3
times a week for the entire 6-week program. Patients were
assessed at baseline and at 6 weeks. Four patients under-
went the training regimen with supplemental oxygen while
three patients in control group received supplemental
oxygen as part of usual care. The goal was to maintain
oxygen saturation 90% in both groups. Patients in the
control group received no physical training, only usual care
that consisted of inhalation and desobstructive maneuvers
(vibration and clapping associated with postural drainage
for 10 min with supported cough).
Statistical analysis
The statistical power analysis and sample size estimation
were calculated based on standard deviation as well as the
difference of HRV indices between pre and post interven-
tion. Twenty subjects in each group was indicated as the
minimum sample size required to assure adequate statis-
tical power (80% and aZ 5%). Continuous data are reported
as mean and SD. Subjects’ characteristics and pulmonaryfunction were compared between groups using the t-test
for continuous variables and by Fisher exact test for cate-
gorical variables. Continuous variables were compared by
two-way repeated measures analysis of variance. When
statistical significance was detected, post-hoc testing
employed the Tukey method. The relationship between the
postepre intervention change (delta) in rMSSD and 6MWT
distance was assessed using Pearson’s correlation. The level
of significance was set at p< 0.05. The analysis was carried
out using the Statistica for Windows software release 5.1
(StatSoft, Inc, Tulsa, OK).
Results
Population characteristics and pulmonary function
Of all patients screened (125), 85 were excluded (see
flowchart in Fig. 1). Forty patients were randomized to
receive aerobic exercise training or usual care. However,
during the study, 6 patients of control group were with-
drawn from the study. Three patients were lost due to
acute exacerbation of COPD, 1 died, 1 presented psychi-
atric problems and 1 could not undergo follow-up assess-
ment due to newly diagnosed ischemic heart disease during
the protocol. Table 1 shows that after randomization, there
were no significant differences between the two groups in
age, anthropometry and lung function. After the results of
pulmonary function testing, patients were characterized,
on average, as having moderate-to-severe airflow obstruc-
tion (FEV1: approximately 40% of the predicted value in
both groups). In addition, reduced respiratory muscle
Figure 2 Delta walking distance correlated significantly with
Delta rMSSD in 20 COPD patients that were trained (rZ 0.65,
pZ 0.001).
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control group (2.6 0.6 years) and four (2.9 0.4 years) in
the aerobic exercise group used domiciliary oxygen therapy
(p> 0.05). During aerobic exercise training, patients in the
experimental group were provided supplemental oxygen to
maintain SpO2 90%.
Effects of aerobic physical exercise program on
exercise capacity
Table 2 illustrates symptom-limited exercise testing and
6MWT results. The aerobic exercise training program
significantly improved (p< 0.05) peak VO2, peak heart rate,
and blood lactate. In addition, at comparable submaximal
exercise intensity, peak dyspnea and perceived exertion
were significantly reduced following aerobic training. No
significant differences in any variables were observed in
control group. Moreover, participation in the aerobic
exercise training program significantly improved 6MWT
distance and rMSSD index during submaximal ambulation
(p< 0.05). Fig. 2 shows the positive, moderate but signifi-
cant correlation between delta 6MWT distance and delta
rMSSD (rZ 0.65; pZ 0.001).
Effects of the aerobic exercise training program on
HRV at rest
Table 3 shows the HRV values in time and frequency domain
in both groups at rest. In the time domain analysis, the
intragroup comparisons showed significant differences inTable 2 Symptom-limited exercise testing and six-minute walk
TG
(nZ 20)
Pre Po
Maximal exercise
Speed (km h1) 3.1 0.9 4
VO2, % pred 58 19 6
VO2, L 0.854 0.19 1.0
VO2, mL kg
1 min1 14 2.2 1
VCO2, mLmin
1 0.947 0.3 1.0
RQ 1.13 0.4 1.0
_VE, L min1 29 5.6 3
Respiratory rate,
breaths min1
32 5 2
Tidal volume, L 0.932 0.26 1.1
Heart rate, bpm 112 13 12
Blood lactate, mMol L1 1.6 0.5 1
Submaximal exercise
Dyspnea 6.0 1.7 4
Leg effort 5.4 1.1 4
Walking distance, m 381 87 48
rMSSD (ms) 6.8 3.5 13
Values expressed in mean and standard deviation. TG: training group
differences between adjacent ReR intervals.
*Significant differences between before and after 6 weeks (p< 0.05)
ySignificant differences after 6 weeks between TG vs. CG (p< 0.05).rMSSD and SDNN index for the experimental group and no
significant differences were observed in control group. In
addition, after 6 weeks, significant differences were
observed in these indexes between groups (p< 0.05). In
relation to frequency domain, AF significantly increased
and BF and BF/AF significantly decreased in the aerobic
training group only (p< 0.05). Significant differences were
only observed for the BF/AF ratio between groups after 6
weeks (p< 0.05). Delta (post pre) of rMSSD index was
comparable at rest and during exercise between groupsing test data.
CG
(nZ 14)
st Pre Post
.1 1.1* 3.1 0.9 3.2 1.0y
8 20* 63 20 64 21
0 0.24* 0.866 0.21 0.861 0.11
6 2.8* 14 3.8 13 4.7
1 0.38 0.961 0.4 1.02 0.28
0 0.2 1.07 0.3 1.17 0.3y
1 6.5* 29 5.7 29 6.2
7 3* 31 5 30 5y
7 0.31* 0.946 0.18 0.966 0.20y
3 13* 112 14 114 14
.9 0.4* 1.6 0.8 1.5 0.5y
.6 1.6* 6.0 2.0 5.8 1.8y
.3 1.0* 6.3 2.6 6.2 2.3y
7 85* 393 96 406 102y
.7 4.0* 6.2 2.8 5.9 3.7y
; CG: Control group; rMSSD: square root of mean of the squared
.
Table 3 Heart rate variability in time and frequency domain on rest in both groups.
TG CG
(nZ 20) (nZ 14)
Pre Post Pre Post
Time domain
rMSSD (ms) 10.1 4.6 19.2 4.9* 11.8 3.0 12.1 4.1y
rMSM (ms) 14.6 6.2 24.8 6.9* 15.5 2.8 16.1 2.4y
Frequency domain
LF (nu) 0.69 0.14 0.47 0.15* 0.64 0.17 0.57 0.26
HF (nu) 0.31 0.1 0.53 0.15* 0.36 0.18 0.43 0.26
LF/HF 3.1 2.3 1.1 0.8* 2.6 1 2.2 1.7y
Values expressed in mean and standard deviation. TG: training group; CG: control group; rMSSD: square root of mean of the squared
differences between adjacent ReR intervals; rMSM: standard deviation of ReR intervals; LF (nu): low frequency in normalized units; HF
(nu): high frequency in normalized units; and LF/HF: low frequency/high frequency ratio.
*Significant differences between before and after 6 weeks (p< 0.05).
ySignificant differences after 6 weeks between TG vs. CG (p< 0.05).
1508 A. Borghi-Silva et al.(Fig. 3). Participation in aerobic exercise training was,
however, associated with a greater increase in rMSSD index
at rest and exercise (p< 0.05).
Discussion
In this randomized clinical trial we were able to demon-
strate that whole-body physical training produced signifi-
cant improvements in submaximal and maximal exercise
capacity in patients with COPD. In addition, this is the first
study, to our knowledge, that compared the positive
effects of 6 weeks of aerobic exercise training on heart rate
variability during rest and exercise in a cohort diagnosed
with this chronic disease. These results potentially have
a high level of clinical relevance given that disorders of
cardiac autonomic control have been associated with the
development of arrhythmias6,7 and sudden death5,27 in the
COPD population. In this context, HRV may prove valuable
in evaluating disease severity,28 assessing risk for future
adverse events and evaluating the positive physiologic
effects of different therapeutic interventions21,29 such as
aerobic exercise training. Future research in this area is
needed to address these issues and more firmly establishFigure 3 Delta of effects of the aerobic exercise training
program at rest and during the 6MWT in both groups.
Note: Only patients in the TG demonstrated a significant
improvement in rMSSD at rest and during exercise in the follow-
up assessment. * Significant differences between TG (in gray)
vs. CG (in black), p< 0.05.the importance of HRV assessment in this chronic disease
population.
Effects of aerobic exercise training on submaximal
and maximal performance
In the present study we observed that 6 weeks of aerobic
exercise training improved submaximal and maximal exer-
cise performance as well as physiological data in COPD
patients (Table 2). Consistent with our results, other groups
have reported that aerobic exercise training is essential in
all stages of COPD.13,14 This form of training can reduce
dyspnea, improve functional capacity and quality of life in
these patients. In addition, aerobic exercise training,
applied 3 times a week can provide beneficial physiological
adaptations in COPD patients.13,14,18,21
A primary novel finding of the present study was
a significant improvement of walking distance and rMSSD in
these patients after physical training and moderate signif-
icant association between delta of walked distance and
rMSSD index (Fig. 2). This finding is not particularly
surprising given that aerobic exercise training has likewise
been shown to improve parasympathetic activity in patients
diagnosed with cardiovascular disease15,16 as well as elderly
sedentary subjects who are apparently healthy.30 In this
context, good aerobic fitness has been suggested to be
associated with increased HRV, most likely attributed to
increased vagal activity in the control of heart rate. In
accordance with these findings, we only observed a signifi-
cant increase in peak VO2 in COPD subjects undergoing
exercise training with no adaptations in the control group.
HRV in COPD patients before and after physical
training
In the present study, we observed that COPD patients
before physical training showed markedly higher levels of
sympathetic activity at rest (Table 3) compared with
previously reported normal HRV values.26 Previous study
has reported that patients with COPD present with reduced
HRV during rest1e3 and exercise.4 However, the main cause
Co
Th
re
Exercise training in COPD 1509of this autonomic disorder is not clear, although some
plausible hypotheses have been posited. Chen et al.8
reported that reduced HRV is associated with hypoxemia in
patients with COPD. In this context, some studies have
been conducted to test the use of oxygen supplementation
in these patients.31 The main finding of these studies3,31 is
that supplemental oxygen could partially reverse auto-
nomic nervous system dysfunction in COPD. Other investi-
gators have focused on the relationship between COPD
severity and reduced HRV. Pagani et al.32 observed
a significant association between HRV indexes and FEV1. In
contrast, Chhabra and De1 reported that cardiovascular
autonomic neuropathy is present in mild as well as
moderate-to-severe COPD. Similarly, we demonstrated that
alterations of autonomic balance are more prevalent in
hypoxemia but also occur in normoxemic patients. In the
present study, we assessed the effects of aerobic exercise
training in COPD patients with or without hypoxemia. Only
four patients were, however, trained with oxygen. The
effects of oxygen therapy on improvement in HRV at rest
and during exercise could therefore not thoroughly be
explored. Based on our findings, it is likely that the positive
adaptations brought about by aerobic exercise training
played a significant contributory role.
More recently, other investigators11 have demonstrated
that cardiac autonomic function of patients with COPD is
not associated with disease severity, but rather the level of
physical activity in daily life. In this context, previous
studies have reported that aerobic exercise training was
associated with improvement of HRV in healthy elderly33
and chronic disease cohorts.15,16 In the present study, we
observed a significant improvement in parasympathetic
activity and reduction of sympathetic activity at rest and
during submaximal exercise after 6 weeks of aerobic
exercise training. A possible explanation for these results is
that the training program employed in the present inves-
tigation may have reduced sympathetic activity by reducing
anxiety,11 and/or catecholamine levels,34 although these
mechanisms remain speculative at this time.
Following aerobic exercise training, the present study
also found a reduction in respiratory rate (RR) and an
increase in tidal volume (TV) during exercise (Table 2).
Other investigators have found that RR reduction and TV
increase can modulate HRV, mainly improving para-
sympathetic activity35 in the control of heart rate. These
adaptations in ventilatory mechanics with our intervention
may also serve as a mechanism for the demonstrated
improvement in autonomic modulation. Moreover, the
observed significant reduction in dyspnea may also be
related to the favorable adaptations in RR and TV.
Another possible explanation for the reduction in
sympathetic activity at rest and during exercise after
aerobic training is due to adaptations in the peripheral
musculature. Heindl et al.36 observed that COPD patients
presented with higher muscle sympathetic nerve activation
compared with healthy subjects. Ischemic metabolites
generated during muscle contraction have been shown to
stimulate local receptors and cause increases in heart rate,
arterial pressure and sympathetic activity.37 In addition,
the increased work of breathing in these patients could
lead to sympathetic activation through stimulation of local
metaboreceptors.36 The positive adaptations brought aboutby aerobic exercise training may help to reverse these
abnormalities.
Finally, lung inflation reflexes can modulate the influ-
ence of vagal modulation on heart rate.35 Dynamic hyper-
inflation is common in COPD patients and negatively impact
hemodynamic adjustments.38 In the present study, we
observed that RR reduced after physical training, concom-
itantly with reduction in dyspnea and improvement in TV.
These adjustments in the respiratory pattern may again
help to explain the improvement of parasympathetic
activity after training.
In conclusion, this randomized clinical trial demonstrates
that a 6-week aerobic exercise training program leads to an
improvement in exercise tolerance, promotes ventilatory
and physiological adaptations and favorably impacts the
derangements in autonomic modulation of heart rate both
at rest and during exercise in patients with COPD.
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